National Cancer Institute

Biologists have been working for decades on cancer research—and they’re making progress. But to really stand a chance against this aggressive disease, we should focus on more interdisciplinary collaboration.

Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."